These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 32108681)
1. Gene therapy for hemophilias: the end of phenotypic testing or the start of a new era? Lippi G; Favaloro EJ Blood Coagul Fibrinolysis; 2020 Jun; 31(4):237-242. PubMed ID: 32108681 [TBL] [Abstract][Full Text] [Related]
2. Emerging genetic and pharmacologic therapies for controlling hemostasis: beyond recombinant clotting factors. Monahan PE Hematology Am Soc Hematol Educ Program; 2015; 2015():33-40. PubMed ID: 26637698 [TBL] [Abstract][Full Text] [Related]
3. Management of hemophilias--gene therapy to come? Vajó Z; Sréter L Acta Physiol Hung; 1996; 84(2):191-8. PubMed ID: 9046365 [TBL] [Abstract][Full Text] [Related]
10. Phenotypic heterogeneity of hemostasis in severe hemophilia. Nogami K; Shima M Semin Thromb Hemost; 2015 Nov; 41(8):826-31. PubMed ID: 25615433 [TBL] [Abstract][Full Text] [Related]
11. Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice. Baumgartner CK; Mattson JG; Weiler H; Shi Q; Montgomery RR J Thromb Haemost; 2017 Jan; 15(1):98-109. PubMed ID: 27496751 [TBL] [Abstract][Full Text] [Related]
12. Hemophilia A gene therapy: current and next-generation approaches. Pipe SW; Gonen-Yaacovi G; Segurado OG Expert Opin Biol Ther; 2022 Sep; 22(9):1099-1115. PubMed ID: 34781798 [TBL] [Abstract][Full Text] [Related]
16. Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII. Margaritis P; Arruda VR; Aljamali M; Camire RM; Schlachterman A; High KA J Clin Invest; 2004 Apr; 113(7):1025-31. PubMed ID: 15057309 [TBL] [Abstract][Full Text] [Related]
17. [Research Progress on Genetic Factors and Hemophilia A Clotting Factor Inhibitor-Review]. Hu ZB; Sun X; He LY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):957-960. PubMed ID: 28641667 [TBL] [Abstract][Full Text] [Related]
18. Helper-dependent adenoviral gene therapy mediates long-term correction of the clotting defect in the canine hemophilia A model. McCORMACK WM; Seiler MP; Bertin TK; Ubhayakar K; Palmer DJ; Ng P; Nichols TC; Lee B J Thromb Haemost; 2006 Jun; 4(6):1218-1225. PubMed ID: 16706963 [TBL] [Abstract][Full Text] [Related]
19. AAV-mediated gene transfer for hemophilia. High KA Ann N Y Acad Sci; 2001 Dec; 953():64-74. PubMed ID: 11795424 [TBL] [Abstract][Full Text] [Related]
20. Advances toward gene therapy for hemophilia at the millennium. Kaufman RJ Hum Gene Ther; 1999 Sep; 10(13):2091-107. PubMed ID: 10498242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]